ARCHIVES

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

This article is from The Cancer Letter archive.

Vol. 20 No. 27 | July 8, 1994

Download PDF Visit The Full Archive

Related Articles

Erbitux Addition to Chemotherapy Regimen Can Make Inoperable Disease Operable

April 26, 2013

NCI Asks $955 Million In ’78; HEW Says $799 Will Be Enough

August 20, 1976

Ungerleider To Leave NCI For Theradex Corp.

November 24, 2000

Guest Editorial: FDA Must Address Economic Incentives to Resolve Drug Shortages Permanently

February 24, 2012

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

October 22, 2010

In Brief: ACCC Lobbyists Got What They Wanted In House Cancer Act Bill; VA Group Review Set May 2

April 28, 1978